- US12187710utility2025Salt of Syk Inhibitor and Crystalline Form Thereof0 cites
- US12150990utility2024Pharmaceutical Composition of Humanized Monoclonal Anti-pd-l1 Antibody0 cites
- US12128047utility2024TLR7 Agonist and Pharmaceutical Combination Thereof for Treating Lung Cancer0 cites
- US12071435utility2024TLR8 Agonist0 cites
- US12054482utility2024TLR8 Agonist0 cites
- US11993596utility2024Fused Tri-cyclic Compound as PDE3/PDE4 Dual Inhibitor0 cites
- US11931506utility2024Dry Powder Inhaler0 cites
- US11891398utility20242,3-dihydro-1h-pyrrolizine-7-formamide Derivative and Application Thereof0 cites
- US11891405utility2024Furo[3,4-b]pyrrole-containing BTK Inhibitor0 cites
- US11866433utility2024Diarylthiohydantoin Compound as Androgen Receptor Antagonist0 cites
- US11834503utility2023Anti-lag-3 Antibodies and Compositions0 cites
- US11731955utility2023Crystal Habit of Quinoline Derivative and Preparation Method for Crystalline Powder Thereof0 cites
- US11702439utility2023Method for Preparing Trifluridine0 cites
- US11667667utility2023Steroid Derivative FXR Agonist0 cites
- US11554115utility2023Quinoline Derivative for Treatment of Triple-negative Breast Cancer0 cites
← PreviousPage 2 of 2